NIH-funded research R01 grant

Circadian Health and Dementia in AD and FTLD patients

Official title: Circadian Disturbance and Dementia

Funded at Massachusetts General Hospital · NIH-11601664 · Data updated 2026-11-12

A study at a major hospital will look at how daily sleep-wake rhythms relate to dementia in people with Alzheimer’s disease or frontotemporal degeneration.

More Dementia research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 15, 2023
Project endJune 30, 2028
Funding year2026
Award (this year)$180,193
NIH project number3R01AG083799-05S3
Project IDNIH-11601664 on NIH RePORTER

Who could benefit from this research

Could help

Adults aged 40–80 with Alzheimer’s disease, frontotemporal lobar degeneration, or without dementia (controls) enrolled in the ReDLat database.

Less likely to help

Individuals outside the age range or not represented in the ReDLat cohorts may not directly benefit.

What this research studies

Researchers at Massachusetts General Hospital will use data from the ReDLat program, examining how circadian disturbances align with dementia symptoms in adults aged 40–80. The project will combine demographic, cognitive, and lifestyle information with circadian measures to understand their relationship to Alzheimer’s disease and FTLD. By analyzing a large, diverse database, the team hopes to identify modifiable circadian factors that could influence disease progression or quality of life. This work builds on existing observations that disrupted sleep and daily rhythms are linked to worse health outcomes in older adults with dementia.

Why it matters

Potential benefit: If successful, findings could guide lifestyle or therapeutic strategies to support circadian health and potentially slow dementia-related decline.

How similar studies have gone: Previous research shows links between circadian disruption and cognitive impairment, but the specific connection to AD and FTLD across diverse settings remains under study.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Hu, Kun — Massachusetts General Hospital
  • Study coordinator: Hu, Kun

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.